Crizotinib-induced acute interstitial lung disease in a patient with EML4-ALK positive non-small cell lung cancer and chronic interstitial pneumonia

Acta Oncologica

Volumn 53, Issue 1, 2014, Pages 158-160

  Watanabe, Naohiro ^a   Nakahara, Yoshio ^a   Taniguchi, Hiroyuki ^a   Kimura, Tomoki ^a   Kondoh, Yasuhiro ^a   Kataoka, Kensuke ^a   Sakamoto, Koji ^b  

^a TOSEI GENERAL HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CARBOPLATIN; CRIZOTINIB; ECHINODERM MICROTUBULE ASSOCIATED PROTEIN LIKE 4; METHYLPREDNISOLONE; MICROTUBULE ASSOCIATED PROTEIN; PACLITAXEL; PEMETREXED; PREDNISOLONE; UNCLASSIFIED DRUG; ECHINODERM MICROTUBULEASSOCIATED PROTEIN LIKE 4; PROTEIN;

AGED; CASE REPORT; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FIBROSING ALVEOLITIS; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL LUNG DISEASE; LETTER; LOW DRUG DOSE; LUNG BIOPSY; LUNG NON SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; MYALGIA; POLYMYOSITIS; PRIORITY JOURNAL; TREATMENT OUTCOME; BRONCHIECTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; INTERSTITIAL PNEUMONIA; NON SMALL CELL LUNG CANCER; OXYGEN BREATHING; OXYGEN SATURATION; POSITIVE END EXPIRATORY PRESSURE;

ACUTE DISEASE; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHRONIC DISEASE; FATAL OUTCOME; HUMANS; LUNG DISEASES, INTERSTITIAL; LUNG NEOPLASMS; MALE; ONCOGENE PROTEINS, FUSION; PROTEIN KINASE INHIBITORS; PYRAZOLES; PYRIDINES;

EID: 84890905455     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2013.802838     Document Type: Letter

References (8)

1. Kudoh S,Kato H, N ishiwaki Y, F ukuoka M, N akata K, Ichinose Y, et al . Interstitial lung disease in Japanese patients with lung cancer: A cohort and nested case-control study . Am J Respir Crit Care Med 2008 ; 177 : 1348-57 . (Pubitemid 351860912)
2. Kwak E L, B ang YJ, C amidge D R, S haw A T, S olomon B, Maki RG, et al . Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer . N Engl J Med 2010 ; 363 : 1693-703 .
3. Camidge D R, B ang Y J, K wak E L, I afrate AJ, V arella-Garcia M, Fox SB, et al . Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: Updated results from a phase 1 study . Lancet Oncol 2012 ; 13 : 1011-9 .
4. Vahid B, M arik PE . P ulmonary complications of novel antineoplastic agents for solid tumors . Chest 2008 ; 133 : 528-38 . (Pubitemid 351272414)
5. Tamiya A, O kamoto I, M iyazaki M, S himizu S, K itaichi M, Nakagawa K . Severe acute interstitial lung disease after crizotinib therapy in a patient with EML4-ALK-positive nonsmall-cell lung cancer . J Clin Oncol 2013 ; 31 : e15-7 .
6. Nakagawa K, K udoh S, O he Y, J ohkoh T, A ndo M, Yamazaki N, et al . Postmarketing surveillance study of erlotinib in Japanese patients with non-small-cell lung cancer (NSCLC): An interim analysis of 3488 patients (POLARSTAR) . J Thorac Oncol 2012 ; 7 : 1296-303 .
7. Minegishi Y, S udoh J, K uribayasi H, M izutani H, S eike M, Azuma A, et al . The safety and effi cacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias . Lung Cancer 2011 ; 71 : 70-4 .
8. Watanabe N, T aniguchi H, K ondoh Y, K imura T, K ataoka K, Nishiyama O, et al . Effi cacy of chemotherapy for advanced non-small cell lung cancer with idiopathic pulmonary fi brosis . Respiration 2013 ; 85 : 326-31 .